WP
Woodline Partners Portfolio holdings
AUM
$18.9B
1-Year Return
23.37%
This Quarter Return
+2.84%
1 Year Return
+23.37%
3 Year Return
+125.78%
5 Year Return
+185.63%
10 Year Return
–
AUM
$14.8B
AUM Growth
+$2.94B
(+25%)
Cap. Flow
+$3.19B
Cap. Flow
% of AUM
21.59%
Top 10 Holdings %
Top 10 Hldgs %
12.57%
Holding
1,027
New
443
Increased
268
Reduced
185
Closed
111
Top Buys
| 1 |
Apple
AAPL
|
+$221M |
| 2 |
NVIDIA
NVDA
|
+$212M |
| 3 |
Microsoft
MSFT
|
+$197M |
| 4 |
Amazon
AMZN
|
+$146M |
| 5 |
Arthur J. Gallagher & Co
AJG
|
+$130M |
Top Sells
| 1 |
ASML
ASML
|
+$125M |
| 2 |
Reddit
RDDT
|
+$111M |
| 3 |
Gilead Sciences
GILD
|
+$110M |
| 4 |
Permian Resources
PR
|
+$84.7M |
| 5 |
Keysight
KEYS
|
+$78.7M |
Sector Composition
| 1 | Healthcare | 32% |
| 2 | Technology | 25.72% |
| 3 | Financials | 7.59% |
| 4 | Industrials | 6.89% |
| 5 | Communication Services | 6.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
551
JD.com
JD
$47.9B
| $3.61M | 0.02% |
104,069
+2,587
| +3% | +$89.7K |
|
552
Portillo's
PTLO
$468M
| $3.57M | 0.02% |
379,672
+198,830
| +110% | +$1.87M |
|
553
Krispy Kreme
DNUT
$527M
| $3.55M | 0.02% |
357,610
-1,324,960
| -79% | -$13.2M |
|
554
Ecolab
ECL
$77.1B
| $3.55M | 0.02% |
+15,135
| New | +$3.55M |
|
555
Oneok
OKE
$45.6B
| $3.52M | 0.02% |
+35,083
| New | +$3.52M |
|
556
General Motors
GM
$55B
| $3.52M | 0.02% |
+66,035
| New | +$3.52M |
|
557
Illinois Tool Works
ITW
$76.5B
| $3.49M | 0.02% |
+13,773
| New | +$3.49M |
|
558
Truist Financial
TFC
$58.5B
| $3.46M | 0.02% |
+79,723
| New | +$3.46M |
|
559
Warby Parker
WRBY
$3.27B
| $3.43M | 0.02% |
141,731
-85,914
| -38% | -$2.08M |
|
|
SLN
560
Silence Therapeutics
SLN
$248M
| $3.43M | 0.02% |
498,732
+91,829
| +23% | +$632K |
|
561
Royal Caribbean
RCL
$94.6B
| $3.43M | 0.02% |
+14,855
| New | +$3.43M |
|
562
Airbnb
ABNB
$76B
| $3.42M | 0.02% |
25,996
-47,943
| -65% | -$6.3M |
|
563
BioCryst Pharmaceuticals
BCRX
$1.69B
| $3.39M | 0.02% |
+450,199
| New | +$3.39M |
|
564
Cheesecake Factory
CAKE
$2.95B
| $3.36M | 0.02% |
70,777
-501,077
| -88% | -$23.8M |
|
565
Bank of New York Mellon
BK
$74.4B
| $3.35M | 0.02% |
+43,664
| New | +$3.35M |
|
566
Sempra
SRE
$52.5B
| $3.34M | 0.02% |
+38,038
| New | +$3.34M |
|
567
Esperion Therapeutics
ESPR
$526M
| $3.31M | 0.02% |
1,503,746
-740,614
| -33% | -$1.63M |
|
568
Neumora Therapeutics
NMRA
$269M
| $3.29M | 0.02% |
310,454
+2,896
| +0.9% | +$30.7K |
|
569
Tourmaline Bio
TRML
$1.22B
| $3.28M | 0.02% |
161,721
+2,567
| +2% | +$52.1K |
|
570
PACCAR
PCAR
$51.3B
| $3.28M | 0.02% |
+31,486
| New | +$3.28M |
|
571
UroGen Pharma
URGN
$954M
| $3.26M | 0.02% |
305,642
| – | – |
|
572
Schlumberger
SLB
$53.9B
| $3.25M | 0.02% |
+84,806
| New | +$3.25M |
|
573
AutoZone
AZO
$71.1B
| $3.25M | 0.02% |
+1,015
| New | +$3.25M |
|
|
RAPP
574
Rapport Therapeutics
RAPP
$1.03B
| $3.22M | 0.02% |
181,530
-5,030
| -3% | -$89.2K |
|
575
Kinder Morgan
KMI
$59.6B
| $3.18M | 0.02% |
+116,074
| New | +$3.18M |
|